Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine -- a PDE1 inhibitor.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  European Journal of Pharmacology

• Publication date

  2009-10-12

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejphar.2009.08.027PMID 19699735
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo effects of phosphodiesterase inhibition on basal cyclic guanosine monophosphate levels in the prefrontal cortex, hippocampus and cerebellum of freely moving rats

  2008cited by this paper
• Effects of Vinpocetine on mitochondrial function and neuroprotection in primary cortical neurons.

  2008cited by this paper
• Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice.

  2008cited by this paper
• [P2.69]: Vinpocetine increase phosphorylation of CREB and restores orientation selectivity in a ferret model of fetal alcohol spectrum disorder

  2008cited by this paper
• [P2.02]: Are the behavioural phenotypes different according to the genotype of iNOS and COX‐2 genes in autism spectrum disorders?

  2008cited by this paper
• Amyloid cascade hypothesis: is it true for sporadic Alzheimer’s disease

  2008cited by this paper
• Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein

  2007cited by this paper
• Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach.

  2007cited by this paper
• Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.

  2007cited by this paper
• Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use

  2006cited by this paper
• Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats.

  2006cited by this paper
• Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats.

  2006cited by this paper
• Improving memory: a role for phosphodiesterases.

  2006cited by this paper
• Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents.

  2006cited by this paper
• Prevention of cognitive impairments and neurodegeneration by Khamira Abresham Hakim Arshad Wala.

  2006cited by this paper
• Single and combined effects of carbamazepine and vinpocetine on depolarization-induced changes in Na+, Ca2+ and glutamate release in hippocampal isolated nerve endings.

  2006cited by this paper
• Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.

  2005cited by this paper
• Diagnosis and Treatment of Alzheimers Disease

  2005cited by this paper
• Eburnamine derivatives and the brain

  2005cited by this paper
• Phosphodiesterase type 5 inhibition improves early memory consolidation of object information.

  2004cited by this paper
• Evidence for genistein mediated cytotoxicity and apoptosis in rat brain.

  2004cited by this paper
• Effect of alpha lipoic acid on intracerebroventricular streptozotocin model of cognitive impairment in rats.

  2003influential reference
• 6-Hydroxymelatonin protects against cyanide induced oxidative stress in rat brain homogenates.

  2003cited by this paper
• Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics

  2003cited by this paper
• [Neuroprotection strategies: effect of vinpocetine in vitro oxidative stress models].

  2003cited by this paper
• [Studying cGMP-dependent mechanisms of vinpocetine effect on smooth muscle cells].

  2003cited by this paper
• A vinca alkaloid enhances morphological dynamics of dendritic spines of neocortical layer 2/3 pyramidal cells.

  2003cited by this paper
• Cyclic AMP-mediated regulation of striatal glutamate release: interactions of presynaptic ligand- and voltage-gated ion channels and G-protein-coupled receptors.

  2003cited by this paper
• cGMP, but not cAMP, in rat hippocampus is involved in early stages of object memory consolidation.

  2002cited by this paper
• Influence of Passive Avoidance Learning by Substance P in the Basolateral Amygdala

  2002cited by this paper
• The role of cGMP hydrolysing phosphodiesterases 1 and 5 in cerebral artery dilatation.

  2001cited by this paper
• Effect of chronic treatment of melatonin on learning, memory and oxidative deficiencies induced by intracerebroventricular streptozotocin in rats.

  2001cited by this paper
• Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization.

  2001cited by this paper
• Ageing and the free radical theory.

  2001cited by this paper
• The effects of phosphodiesterase inhibition on cyclic GMP and cyclic AMP accumulation in the hippocampus of the rat.

  2001cited by this paper
• Synaptosomal response to oxidative stress: Effect of vinpocetine

  2000cited by this paper
• Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease.

  2000cited by this paper
• Role of sodium channel inhibition in neuroprotection: effect of vinpocetine.

  2000cited by this paper
• Metabolism and functions of glutathione in brain.

  2000cited by this paper
• The cholinergic hypothesis of Alzheimer’s disease: a review of progress

  1999cited by this paper
• Cognitive performance and biochemical markers in septum, hippocampus and striatum of rats after an i.c.v. injection of streptozotocin: a correlation analysis.

  1999cited by this paper
• Nitric Oxide Signaling Contributes to Late-Phase LTP and CREB Phosphorylation in the Hippocampus

  1999cited by this paper
• Indole derivatives as neuroprotectants.

  1999cited by this paper
• The specific role of cGMP in hippocampal LTP.

  1998cited by this paper
• The neuroprotective drug vinpocetine prevents veratridine‐induced [Na+]i and [Ca2+]i rise in synaptosomes

  1998cited by this paper
• CREB and memory.

  1998cited by this paper
• Nitric Oxide‐Induced Release of Acetylcholine in the Nucleus Accumbens: Role of Cyclic GMP, Glutamate, and GABA

  1998cited by this paper
• Increased susceptibility of Alzheimer's disease temporal cortex to oxygen free radical-mediated processes.

  1997cited by this paper
• Further evidence for the involvement of a hippocampal cGMP/cGMP‐dependent protein kinase cascade in memory consolidation

  1997cited by this paper
• Induction of CRE-mediated gene expression by stimuli that generate long-lasting LTP in area CA1 of the hippocampus.

  1996cited by this paper
• Hippocampal cGMP and cAMP are differentially involved in memory processing of inhibitory avoidance learning

  1996cited by this paper
• Free radical theory of aging: Alzheimer’s disease pathogenesis

  1995cited by this paper
• High potassium and cyclic AMP analog promote neuronal survival of basal forebrain cholinergic neurons in culture from postnatal 2-week-old rats.

  1994cited by this paper
• Modulation of In Vivo Striatal Transmitter Release by Nitric Oxide and Cyclic GMP

  1994cited by this paper
• Retrieval associated cholinergic activity and its inhibition by memory updating.

  1994cited by this paper
• Age-related changes in signal transduction. Implications for neuronal transmission and potential for drug intervention.

  1994cited by this paper
• Age-Related Changes in Signal Transduction

  1994cited by this paper
• Potentiation of acetylcholine responses in Xenopus embryonic muscle cells by dibutyryl cAMP

  1993cited by this paper
• Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons.

  1993cited by this paper
• Effect of different subtypes of cognition enhancers on long-term potentiation in the rat dentate gyrus in vivo.

  1992cited by this paper
• Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes.

  1991cited by this paper
• Free radicals, antioxidant enzymes, and carcinogenesis.

  1990cited by this paper
• Glutathione metabolism and its selective modification.

  1988cited by this paper
• Vinpocetine enhances retrieval of a step-through passive avoidance response in rats.

  1987cited by this paper
• Effects of vinpocetine in scopolamine‐induced learning and memory impairments

  1987influential reference
• The Biological Substrates of Alzheimer's Disease

  1986cited by this paper
• Vinpocetine: nootropic effects on scopolamine-induced and hypoxia-induced retrieval deficits of a step-through passive avoidance response in rats.

  1986cited by this paper
• Effects of vinpocetine on cyclic nucleotide metabolism in vascular smooth muscle.

  1984cited by this paper
• Cerebral circulatory and cardiac effects of vinpocetine and its metabolite, apovincaminic acid, in anesthetized dogs.

  1984cited by this paper
• Developments of a water-maze procedure for studying spatial learning in the rat.

  1984cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.

  1982cited by this paper
• [The effect of vinpocetine on brain glucose uptake in mice].

  1982cited by this paper
• Post-training amygdaloid lesions impair retention of an inhibitory avoidance response.

  1982cited by this paper
• Biochemical effects of ethyl apovincaminate.

  1976cited by this paper
• Effects of amygdaloid lesions on the performance of rats in four passive avoidance tasks.

  1976cited by this paper
• Mechanisms of lipid peroxide formation in animal tissues.

  1966cited by this paper
• A new and rapid colorimetric determination of acetylcholinesterase activity.

  1961cited by this paper
• Tissue sulfhydryl groups.

  1959cited by this paper
• A virus effect on the uptake of C14 from glucose in vitro by amino acids in mouse brain.

  1951cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Neuroprotective Effect of Perillyl alcohol in Sporadic Alzheimer's disease in Rats.

  2025cites this paper
• Phosphodiesterase Inhibitors: A Therapeutic Approach for Arsenic- Induced Neurotoxicity.

  2025cites this paper
• Catharanthus roseus: A Comprehensive Review of Its Phytochemicals, Therapeutic Potential, and Mechanisms of Action

  2025cites this paper
• Cyclic nucleotide phosphodiesterase 1 and cognitive impairment: Mechanistic insights and therapeutic implications.

  2025cites this paper
• Respiratory Ciliary Beat Frequency in COPD: Balancing Oxidative Stress and Pharmacological Treatment

  2025cites this paper
• Modulation of the cognitive impairment associated with Alzheimer’s disease by valproic acid: possible drug repurposing

  2025cites this paper
• Donepezil-based rational design of N-substituted quinazolinthioacetamide candidates as potential acetylcholine esterase inhibitors for the treatment of Alzheimer's disease: in vitro and in vivo studies.

  2025cites this paper
• Vinpocetine alleviates chemotherapy-induced peripheral neuropathy by reducing oxidative stress and enhancing mitochondrial biogenesis in mice.

  2025cites this paper
• The rapeutic impact of alkaloids in neurological diseases: A promising key molecule

  2024cites this paper
• The ameliorative effect of vinpocetine against gentamicin-induced uterine-injury in rats involves the inflammasome/caspase-1/IL-1β pathway

  2024cites this paper
• Guggulsterone Selectively Modulates STAT-3, mTOR, and PPAR-Gamma Signaling in a Methylmercury-Exposed Experimental Neurotoxicity: Evidence from CSF, Blood Plasma, and Brain Samples

  2024cites this paper
• Bitter yet beneficial: The dual role of dietary alkaloids in managing diabetes and enhancing cognitive function

  2024cites this paper
• Vinpocetine Ameliorates Neuronal Injury After Cold-Induced Traumatic Brain Injury in Mice

  2024cites this paper
• Embelin Mitigates Amyloid-β-Induced Neurotoxicity and Cognitive Impairment in Rats: Potential Therapeutic Implications for Alzheimer’s Disease

  2024cites this paper
• Development of in vitro and in vivo evaluation of mucoadhesive in-situ gel for intranasal delivery of vinpocetine

  2024cites this paper
• Herbal Wisdom for Alzheimer's Disease: A Comprehensive Review

  2024cites this paper
• Regulation of cerebral blood flow boosts precise brain targeting of vinpocetine-derived ionizable-lipidoid nanoparticles

  2024influential citation
• Phosphodiesterase 2 (PDE2) inhibitors: an updated patent review (2017–present)

  2024cites this paper
• Precision medicine: Vinpocetine as a potential treatment for GABRG2-related epilepsy.

  2023cites this paper
• Matrine mediated neuroprotective potential in experimental multiple sclerosis: Evidence from CSF, blood markers, brain samples and in-silico investigations.

  2023cites this paper
• Anti-Alzheimer Activity of Combinations of Cocoa with Vinpocetine or Other Nutraceuticals in Rat Model: Modulation of Wnt3/β-Catenin/GSK-3β/Nrf2/HO-1 and PERK/CHOP/Bcl-2 Pathways

  2023cites this paper
• Neuroprotective effects of vinpocetine, as a phosphodiesterase 1 inhibitor, on long-term potentiation in a rat model of Alzheimer’s disease

  2023cites this paper
• Erucic acid ameliorates the lipopolysaccharide‐induced memory deficit in rats through inhibited inflammation cytokines expression/caspase 3/NF‐κB pathways

  2023cites this paper
• Advances in targeting Phosphodiesterase 1: From mechanisms to potential therapeutics.

  2023cites this paper
• New insights on the potential effect of vinpocetine in Parkinson’s disease: one of the neglected warden and baffling topics

  2023cites this paper
• Neuroprotective Efficacy of Europinidin in Streptozotocin-Induced Memory Impairment by Modulation of Oxidative Stress, Inflammatory Mediators, and Cholinesterase Activity in Rats

  2023cites this paper
• Design and Biological Evaluation of Repaglinide Loaded Polymeric Nanocarriers for Diabetes Linked Neurodegenerative Disorder: QbD-Driven Optimization, In Situ, In Vitro and In Vivo Investigation.

  2023cites this paper
• Drugs/agents for the treatment of ischemic stroke: Advances and perspectives

  2023cites this paper
• Therapeutic potential of phosphodiesterase inhibitors for cognitive amelioration in Alzheimer's disease.

  2022cites this paper
• Guggulsterone Mediated JAK/STAT and PPAR-Gamma Modulation Prevents Neurobehavioral and Neurochemical Abnormalities in Propionic Acid-Induced Experimental Model of Autism

  2022cites this paper
• 4-hydroxyisoleucine mediated IGF-1/GLP-1 signalling activation prevents propionic acid-induced autism-like behavioural phenotypes and neurochemical defects in experimental rats.

  2022cites this paper
• Protective effects of apigenin on methylmercury-induced behavioral/neurochemical abnormalities and neurotoxicity in rats

  2022cites this paper
• Potential role of IP3/Ca2+ signaling and phosphodiesterases: Relevance to neurodegeneration in Alzheimer's disease and possible therapeutic strategies.

  2022cites this paper
• Rosinidin Protects Streptozotocin-Induced Memory Impairment-Activated Neurotoxicity by Suppressing Oxidative Stress and Inflammatory Mediators in Rats

  2022cites this paper
• Anti-Huntington’s Effect of Butin in 3-Nitropropionic Acid-Treated Rats: Possible Mechanism of Action

  2022cites this paper
• Algerian Capparis spinosa n-BuOH Extract Alleviates Diabetic Neuropathy Induced with Streptozotocin in Ratss

  2022cites this paper
• Butin Mitigates Memory Impairment in Streptozotocin-Induced Diabetic Rats by Inhibiting Oxidative Stress and Inflammatory Responses

  2022cites this paper
• Effect of Natural Adenylcyclase/cAMP/CREB Signalling Activator Forskolin against Intra-Striatal 6-OHDA-Lesioned Parkinson’s Rats: Preventing Mitochondrial, Motor and Histopathological Defects

  2022cites this paper
• Beta-Boswellic Acid Reverses 3-Nitropropionic Acid-Induced Molecular, Mitochondrial, and Histopathological Defects in Experimental Rat Model of Huntington’s Disease

  2022cites this paper
• Forskolin, an Adenylcyclase/cAMP/CREB Signaling Activator Restoring Myelin-Associated Oligodendrocyte Destruction in Experimental Ethidium Bromide Model of Multiple Sclerosis

  2022cites this paper
• Vinpocetine restores cognitive and motor functions in Traumatic brain injury challenged rats

  2022cites this paper
• RETRACTED: Activating SIRT-1 Signalling with the Mitochondrial-CoQ10 Activator Solanesol Improves Neurobehavioral and Neurochemical Defects in Ouabain-Induced Experimental Model of Bipolar Disorder

  2022cites this paper
• Activation of IGF-1/GLP-1 Signalling via 4-Hydroxyisoleucine Prevents Motor Neuron Impairments in Experimental ALS-Rats Exposed to Methylmercury-Induced Neurotoxicity

  2022cites this paper
• Nrf2/HO-1 Signaling Stimulation through Acetyl-11-Keto-Beta-Boswellic Acid (AKBA) Provides Neuroprotection in Ethidium Bromide-Induced Experimental Model of Multiple Sclerosis

  2022cites this paper
• Smo-Shh signaling activator purmorphamine ameliorates neurobehavioral, molecular, and morphological alterations in an intracerebroventricular propionic acid-induced experimental model of autism

  2021cites this paper
• Role of phosphodiesterase 1 in the pathophysiology of diseases and potential therapeutic opportunities.

  2021cites this paper
• Thiamme2-G, a Novel O-GlcNAcase Inhibitor, Reduces Tau Hyperphosphorylation and Rescues Cognitive Impairment in Mice

  2021cites this paper
• Solanesol Mediated SIRT-1 Activation Prevents Neurobehavioral and Neurochemical Defects in Ouabain-Induced Experimental Model of Bipolar Disorder in Rats

  2021cites this paper
• Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and morphological alterations in rat brain

  2021cites this paper
• Phosphodiesterase type 1 inhibition alters medial prefrontal cortical activity during goal-driven behaviour and partially reverses neurophysiological deficits in the rat phencyclidine model of schizophrenia.

  2021cites this paper
• Solanesol Mediated SIRT-1 Signaling Activation Prevents Neurobehavioral and Neurochemical Defects in Ouabain-induced Experimental Model of Bipolar Disorder in Rats

  2021influential citation
• PI3K/AKT/mTOR signalling inhibitor chrysophanol ameliorates neurobehavioural and neurochemical defects in propionic acid-induced experimental model of autism in adult rats

  2021cites this paper
• Nrf2/HO-1 Signaling Activator Acetyl-11-keto-beta Boswellic Acid (AKBA)-Mediated Neuroprotection in Methyl Mercury-Induced Experimental Model of ALS

  2021cites this paper
• Natural Molecules as Talented Inhibitors of Nucleotide Pyrophosphatases/Phosphodiesterases (PDEs).

  2021cites this paper
• PI3K/AKT/mTOR Signalling Inhibitor Chrysophanol Ameliorates Neurobehavioural and Neurochemical Defects in Propionic Acid-induced Experimental Model of Autism

  2021cites this paper
• Neuroprotection by solanesol against ethidium bromide-induced multiple sclerosis-like neurobehavioral, molecular, and neurochemical alterations in experimental rats

  2021cites this paper
• IGF-1/GLP-1 Signaling Activator 4-hydroxyisoleucine (4-HI) Prevent Neurobehavioral and Neurochemical Defects in Methylmercury-induced Experimental Model of ALS: Insights From CSF, Blood Plasma and Brain Homogenate Samples in Rats

  2021cites this paper
• Neuroprotective Effect of α-Mangostin in Ameliorating Propionic Acid-Induced Experimental Model of Autism in Wistar Rats

  2021cites this paper
• Animal models of chemotherapy-induced cognitive decline in preclinical drug development

  2021cites this paper
• Vinpocetine, cognition, and epilepsy.

  2021cites this paper
• Advances in Cyclic Nucleotide Phosphodiesterase-Targeted PET Imaging and Drug Discovery.

  2021cites this paper
• Cerebral Cortex and Hippocampal Protection Mediated by Callistemon viminalis in Aluminium Chloride Induced Alzheimer’s Disease

  2020cites this paper
• Chebulinic Acid Negated the Development of Streptozotocin- Induced Experimental Dementia in Rats

  2020cites this paper
• Allium cepa fraction attenuates STZ-induced dementia via cholinesterase inhibition and amelioration of oxidative stress in mice

  2020cites this paper
• Vinpocetine and Ischemic Stroke

  2020cites this paper
• Oral treatment with royal jelly improves memory and presents neuroprotective effects on icv-STZ rat model of sporadic Alzheimer's disease

  2020cites this paper
• Preconditioning with PDE1 Inhibitors and Moderate-Intensity Training Positively Affect Systemic Redox State of Rats

  2020cites this paper
• The protective and therapeutic effects of vinpocetine, a PDE1 inhibitor, on oxidative stress and learning and memory impairment induced by an intracerebroventricular (ICV) injection of amyloid beta (Aβ) peptide.

  2020cites this paper
• Ebselen reversed peripheral oxidative stress induced by a mouse model of sporadic Alzheimer's disease

  2020cites this paper
• Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies.

  2020cites this paper
• Strength exercise suppresses STZ‐induced spatial memory impairment and modulates BDNF/ERK‐CAMKII/CREB signalling pathway in the hippocampus of mice

  2020cites this paper
• Morin hydrate attenuates chronic stress-induced memory impairment and degeneration of hippocampal subfields in mice: The role of oxidative, nitrergic and neuroinflammatory pathways

  2020cites this paper
• Therapeutic Potential of Phosphodiesterase Inhibitors against Neurodegeneration: The Perspective of the Medicinal Chemist

  2020cites this paper
• Binge and Subchronic Exposure to Ketamine Promote Memory Impairments and Damages in the Hippocampus and Peripheral Tissues in Rats: Gallic Acid Protective Effects

  2020cites this paper
• Vinpocetine facilitates the anti-amnesic activity of estrogen-receptor alpha agonist in bilateral ovariectomy-challenged animals.

  2020cites this paper
• Updates of Recent Vinpocetine Research in Treating Cardiovascular Diseases

  2020cites this paper
• Role of vinpocetine in ischemic stroke and poststroke outcomes: A critical review

  2020cites this paper
• Piperine attenuates cognitive impairment in an experimental mouse model of sporadic Alzheimer's disease.

  2019cites this paper
• Vinpocetine mitigates aluminum-induced cognitive impairment in socially isolated rats.

  2019cites this paper
• Protective effects of 5-HT1A receptor antagonist and 5-HT2A receptor agonist on the biochemical and histological features in a rat model of Alzheimer's disease.

  2019cites this paper
• Dendritic spines: Revisiting the physiological role.

  2019cites this paper
• A PDE1 inhibitor reduces adipogenesis in mice via regulation of lipolysis and adipogenic cell signaling

  2019cites this paper
• A multifunctional compound ebselen reverses memory impairment, apoptosis and oxidative stress in a mouse model of sporadic Alzheimer's disease.

  2019cites this paper
• Potential Enzymatic Targets in Alzheimer's: A Comprehensive Review.

  2019cites this paper
• Neuroprotective potential of phytochemicals via in silico molecular docking techniques

  2019cites this paper
• Aegle marmelos leaf extract ameliorates the cognitive impairment and oxidative stress induced by intracerebroventricular streptozotocin in male rats

  2019cites this paper
• Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer's Disease.

  2018cites this paper
• Protective effect of betulinic acid against intracerebroventricular streptozotocin induced cognitive impairment and neuronal damage in rats: Possible neurotransmitters and neuroinflammatory mechanism

  2018cites this paper
• Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington's disease-like behavioral, biochemical, and cellular alterations: Restoration of coenzyme-Q10-mediated mitochondrial dysfunction

  2018cites this paper
• Protective effect of vinpocetine against neurotoxicity of manganese in adult male rats

  2018cites this paper
• Effects of Chronic Lithium Chloride and L-Arginine Treatment on Prevention of Streptozotocin Induced Cognitive Deficits by Ellagic Acid

  2018cites this paper
• Modulation of P2X Purinoceptor 3 (P2X3) in Pentylenetetrazole-Induced Kindling Epilepsy in Rats

  2018cites this paper
• Targeting the NO/cGMP/CREB Phosphorylation Signaling Pathway in Alzheimer’s Disease

  2018cites this paper
• Vinpocetine protects inner retinal neurons with functional NMDA glutamate receptors against retinal ischemia

  2018cites this paper
• An update on vinpocetine: New discoveries and clinical implications

  2018cites this paper
• Inhibition of phosphodiesterases as a strategy to achieve neuroprotection in Huntington's disease

  2018cites this paper
• Protective effects of evodiamine in experimental paradigm of Alzheimer’s disease

  2018cites this paper
• Targeting central &bgr;2 receptors ameliorates streptozotocin‐induced neuroinflammation via inhibition of glycogen synthase kinase3 pathway in mice

  2018cites this paper
• From Age-Related Cognitive Decline to Alzheimer's Disease: A Translational Overview of the Potential Role for Phosphodiesterases.

  2017cites this paper
• Phosphodiesterases: CNS Functions and Diseases

  2017cites this paper